Table 2.

Cardiac conditions of the enrolled patients

Reference	Year	Setting	LVEF (%)	NYHA class	Proportion of patients with HF of ischaemic aetiology (%)
Mavrogeni et al. 13	2007	CHF (LVEF <30%)	22 ± 6 (levosimendan group); 22 ± 5 (control group)	III–IV	50
Kleber et al. 14	2009	Pulmonary hypertension with signs of right HF in the previous 6 months	Not reported	III–IV	Not available
Bonios et al. 15	2012	Chronic systolic HF with recent decompensation	23 ± 7 (levosimendan group); 21 ± 5 (control group)	IV	50
Malfatto et al. 16	2012	CHF (LVEF <35%) requiring at least two hospitalizations in the previous 6 months	26 ± 5 (levosimendan group); 28 ± 8 (control group)	3 ± 0.4 (levosimendan group); 3 ± 0.4 (control group)	72
Comin‐Colet et al. 17	2015	CHF (LVEF <35%) with decompensation in the previous 12 months	25 ± 7 (levosimendan group); 25 ± 6 (control group)	III–IV	61
García‐González et al . 18	2016	CHF with decompensation in the previous 6 months	25 ± 8 (levosimendan group); 26 ± 10 (control group)	III–IV	Not available

CHF, chronic heart failure; HF, heart failure; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.